Potter WZ

References (2)

Title : Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia - Shekhar_2008_Am.J.Psychiatry_165_1033
Author(s) : Shekhar A , Potter WZ , Lightfoot J , Lienemann J , Dube S , Mallinckrodt C , Bymaster FP , McKinzie DL , Felder CC
Ref : Am J Psychiatry , 165 :1033 , 2008
Abstract : Shekhar_2008_Am.J.Psychiatry_165_1033
ESTHER : Shekhar_2008_Am.J.Psychiatry_165_1033
PubMedSearch : Shekhar_2008_Am.J.Psychiatry_165_1033
PubMedID: 18593778

Title : Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease - Bodick_1997_Arch.Neurol_54_465
Author(s) : Bodick NC , Offen WW , Levey AI , Cutler NR , Gauthier SG , Satlin A , Shannon HE , Tollefson GD , Rasmussen K , Bymaster FP , Hurley DJ , Potter WZ , Paul SM
Ref : Archives of Neurology , 54 :465 , 1997
Abstract : Bodick_1997_Arch.Neurol_54_465
ESTHER : Bodick_1997_Arch.Neurol_54_465
PubMedSearch : Bodick_1997_Arch.Neurol_54_465
PubMedID: 9109749